Company / Income Tax per Share
Protalix BioTherapeutics, Inc. Income Tax per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2022-FY2025
Trend
-53.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax per Share has declined for 3 consecutive years, from $0.01 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -34.0%.
Improved from $0.01 to $0.00 over the past 2 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -34.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Protalix BioTherapeutics, Inc.'s income tax per share has declined for 3 consecutive years.
- In FY2025, income tax per share decreased 53.9% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -53.9% |
| FY2024 | $0.01 | -26.3% |
| FY2023 | $0.01 | -15.3% |
| FY2022 | $0.01 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026